RA Capital Management, L.P. 13D/13G Filings for C4 Therapeutics, Inc. (CCCC)

RA Capital Management, L.P. 13D and 13G filings for C4 Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-12-26
4:30 pm
Purchase
2023-12-14 13G C4 Therapeutics, Inc.
CCCC
RA Capital Management, L.P. 4,878,000
9.900%
4,878,000increase
(New Position)
Filing